Podgajnyj D. Development and standardization of new antidiabetic drug on the basis of diacamph and metformin.

Українська версія

Thesis for the degree of Candidate of Sciences (CSc)

State registration number

0410U006619

Applicant for

Specialization

  • 15.00.03 - Стандартизація та організація виробництва лікарських засобів

14-12-2010

Specialized Academic Board

Д 64.817.0

Essay

First the domestic original substance of diacamph was used for creating com-bined antidiabetic drug. Pharmaceutical combination of two medicinal substance is offered - diacamph and metformin for creation on their basis of antidiabetic drug. The conducted pharmacological researches are set potency of hypolipidemic, antia-therogenic and antioxidation properties of diacamph and metformin, and also decline in 5,3 times toxic properties of metformin in pharmaceutical combination with dia-camph.On the basis of complex physical, chemical and technological researches com-position is offered and rational technology of capsules of antidiabetic action which is worked in industrial terms is developed. The methods of standardization of antidia-betic drug are developed in capsules with proper validation of spectrophotometric de-termination of quantitative content of diacamph and metformin in a drug.

Files

Similar theses